These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 12019118)
1. Amphotericin B formulations exert additive antifungal activity in combination with pulmonary alveolar macrophages and polymorphonuclear leukocytes against Aspergillus fumigatus. Roilides E; Lyman CA; Filioti J; Akpogheneta O; Sein T; Lamaignere CG; Petraitiene R; Walsh TJ Antimicrob Agents Chemother; 2002 Jun; 46(6):1974-6. PubMed ID: 12019118 [TBL] [Abstract][Full Text] [Related]
2. Deoxycholate amphotericin B and amphotericin B lipid complex exert additive antifungal activity in combination with pulmonary alveolar macrophages against Fusarium solani. Roilides E; Lyman CA; Armstrong D; Stergiopoulou T; Petraitiene R; Walsh TJ Mycoses; 2006 Mar; 49(2):109-13. PubMed ID: 16466443 [TBL] [Abstract][Full Text] [Related]
3. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus. Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2006 Mar; 50(3):868-73. PubMed ID: 16495244 [TBL] [Abstract][Full Text] [Related]
4. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus. Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514 [TBL] [Abstract][Full Text] [Related]
5. Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus. Simitsopoulou M; Roilides E; Georgiadou E; Paliogianni F; Walsh TJ Med Mycol; 2011 Feb; 49(2):176-85. PubMed ID: 20807031 [TBL] [Abstract][Full Text] [Related]
6. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations. Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824 [TBL] [Abstract][Full Text] [Related]
7. Comparative efficacies, toxicities, and tissue concentrations of amphotericin B lipid formulations in a murine pulmonary aspergillosis model. Olson JA; Adler-Moore JP; Schwartz J; Jensen GM; Proffitt RT Antimicrob Agents Chemother; 2006 Jun; 50(6):2122-31. PubMed ID: 16723574 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the in vitro activity of human neutrophils against Aspergillus fumigatus in presence of antifungal and immunosuppressive agents. Decker C; Wurster S; Lazariotou M; Hellmann AM; Einsele H; Ullmann AJ; Löffler J Med Mycol; 2018 Jun; 56(4):514-519. PubMed ID: 29420763 [TBL] [Abstract][Full Text] [Related]
9. Dose range evaluation of liposomal nystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B. Denning DW; Warn P Antimicrob Agents Chemother; 1999 Nov; 43(11):2592-9. PubMed ID: 10543734 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell level. Jahn B; Rampp A; Dick C; Jahn A; Palmer M; Bhakdi S Antimicrob Agents Chemother; 1998 Oct; 42(10):2569-75. PubMed ID: 9756757 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus. Al-Nakeeb Z; Petraitis V; Goodwin J; Petraitiene R; Walsh TJ; Hope WW Antimicrob Agents Chemother; 2015 May; 59(5):2735-45. PubMed ID: 25712363 [TBL] [Abstract][Full Text] [Related]
12. In vitro interaction between alginate lyase and amphotericin B against Aspergillus fumigatus biofilm determined by different methods. Bugli F; Posteraro B; Papi M; Torelli R; Maiorana A; Paroni Sterbini F; Posteraro P; Sanguinetti M; De Spirito M Antimicrob Agents Chemother; 2013 Mar; 57(3):1275-82. PubMed ID: 23263007 [TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum. Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027 [TBL] [Abstract][Full Text] [Related]
14. Toxicity and efficacy differences between liposomal amphotericin B formulations in uninfected and Aspergillus fumigatus infected mice. Olson JA; Schwartz JA; Hahka D; Nguyen N; Bunch T; Jensen GM; Adler-Moore JP Med Mycol; 2015 Feb; 53(2):107-18. PubMed ID: 25550388 [TBL] [Abstract][Full Text] [Related]
15. Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes. Simitsopoulou M; Roilides E; Maloukou A; Gil-Lamaignere C; Walsh TJ Mycoses; 2008 Mar; 51(2):147-54. PubMed ID: 18254752 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatus. Otsubo T; Maesaki S; Hossain MA; Yamamoto Y; Tomono K; Tashiro T; Seki J; Tomii Y; Sonoke S; Kohno S Antimicrob Agents Chemother; 1999 Mar; 43(3):471-5. PubMed ID: 10049253 [TBL] [Abstract][Full Text] [Related]
17. Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. Sivak O; Bartlett K; Risovic V; Choo E; Marra F; Batty DS; Wasan KM J Pharm Sci; 2004 Jun; 93(6):1382-9. PubMed ID: 15124198 [TBL] [Abstract][Full Text] [Related]
18. In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae. Lass-Flörl C; Nagl M; Gunsilius E; Speth C; Ulmer H; Würzner R Mycoses; 2002 Jun; 45(5-6):166-9. PubMed ID: 12100533 [TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus. Stergiopoulou T; Meletiadis J; Sein T; Papaioannidou P; Walsh TJ; Roilides E Antimicrob Agents Chemother; 2011 Dec; 55(12):5923-9. PubMed ID: 21911564 [TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of amphotericin B lipid complex and liposomal amphotericin B kinetics of lung accumulation and fungal clearance in a murine model of acute invasive pulmonary aspergillosis. Lewis RE; Liao G; Hou J; Chamilos G; Prince RA; Kontoyiannis DP Antimicrob Agents Chemother; 2007 Apr; 51(4):1253-8. PubMed ID: 17261624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]